Literature DB >> 111930

Purification of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital.

K W Bock, D Josting, W Lilienblum, H Pfeil.   

Abstract

Glucuronidation reactions catalysed by rat liver microsomal UDP-glucuronyltransferase are differentially inducible by 3-methylcholanthrene and phenobarbital. To elucidate the molecular basis of this functional heterogeneity the enzyme was purified from livers of rats pretreated with the inducing agents. Using cholate solubilization, chromatography on Bio-Gel A-1.5m and on DEAE-cellulose in the presence of the nonionic detergent Brij 58, two enzyme forms could be separated. Both forms were subsequently purified to apparent homogeneity by affinity chromatography on UDP-hexanolamine Sepharose 4B, 3-Methylcholanthrene-inducible enzyme activity towards 1-naphthol, 4-nitrophenol, 3-hydroxybenzo(a)pyrene and N-hydroxy-2-naphthylamine copurified with one enzyme form (enzyme 1). In contrast phenobarbital-inducible enzyme activity towards morphine, chloramphenicol and 4-hydroxybiphenyl was associated with the other enzyme fraction (enzyme 2). Sodium dodecylsulfate/polyacrylamide gels showed similar molecular weights of 54000 for enzyme 1 and 56000 for enzyme 2. The results suggest the presence of at least two forms of UDP-glucuronyltransferase in rat liver. Factors affecting enzyme activity in purified and membrane-bound states are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111930     DOI: 10.1111/j.1432-1033.1979.tb13155.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  Substrate specificity and characterization of rat liver p-nitrophenol, 3 alpha-hydroxysteroid and 17 beta-hydroxysteroid UDP-glucuronosyltransferases.

Authors:  C N Falany; M D Green; E Swain; T R Tephly
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

2.  Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase.

Authors:  J Roy Chowdhury; N Roy Chowdhury; C N Falany; T R Tephly; I M Arias
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

3.  Genetic deficiency of androsterone UDP-glucuronosyltransferase activity in Wistar rats is due to the loss of enzyme protein.

Authors:  M Matsui; F Nagai
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

4.  Effects of phenobarbital pretreatment on the in vivo metabolism of carbaryl in rats.

Authors:  E V Knight; A P Alvares; B H Chin
Journal:  Bull Environ Contam Toxicol       Date:  1987-11       Impact factor: 2.151

5.  Immunohistochemical demonstration of increased UDP-glucuronyltransferase in putative preneoplastic liver foci.

Authors:  G Fischer; A Schauer; K W Bock; D Ullrich; N Katz
Journal:  Naturwissenschaften       Date:  1983-03

6.  The separation and purification of rat liver UDP-glucuronyltransferase activities towards testosterone and oestrone.

Authors:  P J Weatherill; B Burchell
Journal:  Biochem J       Date:  1980-08-01       Impact factor: 3.857

Review 7.  The role of conjugation reactions in detoxication.

Authors:  K W Bock; W Lilienblum; G Fischer; G Schirmer; B S Bock-Henning
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

8.  Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking.

Authors:  R Fleischmann; H Remmer; U Stärz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Properties of human hepatic UDP-glucuronosyltransferases. Relationship to other inducible enzymes in patients with cholestasis.

Authors:  S Dragacci; J Thomassin; J Magdalou; H Souhaili El Amri; P Boissel; G Siest
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.